(Q34499694)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11799479%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11799479%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

main subject

liver transplantation

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11799479%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

Forrest S Dodson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11799479%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Jorge Rakela

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11799479%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11799479%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

published in

Liver Transplantation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11799479%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11799479%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11799479%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

2-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11799479%20AND%20SRC:MED&resulttype=core&format=json

Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Liver transplantation in hepatitis delta virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

'EUROHEP' consensus report on the management of liver transplantation for hepatitis B virus infection. European Concerted Action on Viral Hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Should liver transplantation be performed for patients with chronic hepatitis B? Yes!

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Hepatitis B immune globulin to prevent hepatitis B virus graft reinfection following liver transplantation: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Modulation of the immunological response to hepatitis B virus by antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Incidence and clinical consequences of surface and polymerase gene mutations in liver transplant recipients on hepatitis B immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Hepatitis B virus mutations in the pre-S genome before and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Vaccine-induced escape mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Emergence of hepatitis B virus S gene mutant in a liver transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Hepatitis B virus surface mutations associated with infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Clinical potential of emerging new agents in hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Histopathology of a human allografted kidney with clinically sufficient function

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Developing strategies for prevention and treatment of recurrent HBV in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Treatment of hepatitis B-reinfection or de novo-infection after liver transplantation with famciclovir--how effective is it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Posttransplantation prevention and treatment of recurrent hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

"Occult" hepatitis B virus as source of infection in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Infectivity of hepatic allografts with antibodies to hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Laparoscopic study of peliosis hepatis and nodular transformation of the liver before and after renal transplantation: natural history and aetiology in follow-up cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Liver transplantation and de novo hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

De novo and apparent de novo hepatitis B virus infection after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765

Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.29765